Industry
The last six years we generated more than $7.3 billion worth of economic impact in our area.
The impact of our technological advancements on scientific research is profound, particularly in how we address the bottleneck in lab productivity.
Despite the generics industry dispensing 90% of prescription medication in the US, it faces continuous price deflation, making sustainability a critical concern.
Our substantial access to trial data, thanks to our involvement in a significant portion of FDA-approved drug trials, positions us uniquely to develop impactful AI algorithms enhancing privacy and both the speed and consistency of data analysis.
While cancer remains our primary focus, our long-term vision includes establishing gedatolisib as a cornerstone treatment in both oncology and other disease areas, potentially making it one of the most important drug launches this decade.
At Arcutis Biotherapeutics, our approach to drug development is distinctively problem-focused rather than being platform-based.
SK pharmteco has four key breakthrough objectives: 1. Become a Top Tier Employer; 2. Be the most Valued CDMO Partner; 3. Relentlessly Strive for Excellence; and 4. Continuously Demonstrate Leading Capabilities.
The profound potential impact of AI and biology on human lives drives my passion for this field.
In the realm of life sciences, two pivotal forces steer advancements: the quest for efficiencies within the healthcare system and the pursuit of an enhanced quality of life for patients.
At Redwire, we specialize in developing research equipment and facilities for space to discover new opportunities that can improve human health on Earth.
